Hyphens Pharma News

Investors in Hyphens Pharma International (Catalist:1J5) Have Seen Favorable Returns of 75% Over the Past Five Years

Yahoo FinanceApr 24 06:06

Hyphens Pharma's Attributable Profit Narrows in 2023

Hyphens Pharma (SGX:1J5) booked a lower attributable profit to equity holders of SG$8.6 million for the year ended Dec. 31, 2023, compared with SG$11.4 million in the year-ago period, according to a f

MT NewswiresApr 9 14:16

Huationg Global CEO Increases Interest to 7.75%

Huationg Global CEO increases interest to 7.75%INSTITUTIONS were net buyers of Singapore stocks over the four trading sessions until Apr 4 inclusive, with S$49 million of net institutional inflow, as

Singapore ExchangeApr 8 09:34

Hyphens Pharma Buys Back Shares

Hyphens Pharma International (SGX:1J5) bought back 471,200 shares in the open market on Tuesday, its first purchase since the board approved a buyback program of up to 30.9 million shares last year, a

MT NewswiresApr 3 10:56

CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.35 From SG$0.32, Keeps at Add

02:34 AM EDT, 03/15/2024 (MT Newswires) -- CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.35 From SG$0.32, Keeps at Add Price (SGD): S$0.29, Change: S$0.00, Percent Change: 0.00%

MT NewswiresMar 15 14:34

Hyphens Pharma Obtains License to MC2's Psoriasis Cream

Hyphens Pharma International (SGX:1J5) obtained an exclusive license to register and commercialize MC2 Therapeutics' Wynzora plaque psoriasis cream in all 10 member countries of the Association of Sou

MT NewswiresMar 13 13:47

Hyphens Pharma Licenses Wynzora® Cream for ASEAN Countries From MC2 Therapeutics

Hyphens Pharma International Limited ("Hyphens Pharma", or the "Company", and together with its subsidiaries, the "Group"), Singapore's leading...

PR NewswireMar 12 18:12

Hyphens Pharma International Full Year 2023 Earnings: Beats Expectations

Yahoo FinanceFeb 29 06:05

Hyphens Pharma Strikes Distribution Deal With 7-Eleven Singapore

Hyphens Pharma International (SGX:1J5) said it will sell its homegrown brand of Ocean Health supplements at selected 7-Eleven stores in Singapore. The collaboration marks the group's foray into the co

MT NewswiresFeb 13 21:05

Hyphens Pharma International Grants Nearly 6 Million Shares Under Performance Share Plan

Hyphens Pharma International (SGX:1J5) granted a total of 5,854,418 shares to employees under its performance share plan on Friday. Of the total, 2,137,118 shares were granted to Lim See Wah, the comp

MT NewswiresDec 11, 2023 17:11

CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.32 From SG$0.34, Keeps at Add

05:14 AM EST, 11/28/2023 (MT Newswires) -- CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.32 From SG$0.34, Keeps at Add Price (SGD): S$0.28, Change: S$0.00, Percent Change: -1.79%

MT NewswiresNov 28, 2023 18:14

Hyphens Pharma International Limited's (Catalist:1J5) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Yahoo FinanceNov 9, 2023 14:38

Hyphens Pharma Unit Completes Purchase of First Tranche of Remaining Ardence Pharma Stake

Hyphens Pharma International's (SGX:1J5) Hyphens Pharma subsidiary has completed the previously announced purchase of a 23% stake in Malaysia's Ardence Pharma, according to a Wednesday disclosure. The

MT NewswiresNov 9, 2023 07:39

Hyphens Pharma to Acquire Remaining 58% Stake in Ardence Pharma

Hyphens Pharma International (SGX:1J5), via its unit Hyphens Pharma, is acquiring the remaining 58% stake in Ardence Pharma in three tranches. Under first tranche, the pharmaceutical company will acqu

MT NewswiresOct 18, 2023 15:00

Is There An Opportunity With Hyphens Pharma International Limited's (Catalist:1J5) 44% Undervaluation?

Yahoo FinanceSep 23, 2023 06:04

Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia

Hyphens Pharma International (SGX:1J5) said its subsidiary Hyphens Pharma will distribute and sell Daewoong Pharmaceutical's (KRX:069620) botulinum toxin formulation, Nabota, in Malaysia. The Nabota b

MT NewswiresAug 30, 2023 19:15

Do Hyphens Pharma International's (Catalist:1J5) Earnings Warrant Your Attention?

Yahoo FinanceJul 28, 2023 07:18

Hyphens Pharma Names CFO

Hyphens Pharma International (SGX:1J5) appointed Zhang Yufan as its chief financial officer effective June 12, according to a Monday filing. Prior to joining the company, Zhang was previously CFO of T

MT NewswiresJun 5, 2023 20:06

Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore

Singapore's Straits Times broke the losing streak to close higher on Thursday, after US stocks rose sharply on Wednesday on hopes that the US will avoid a debt default. During the day, the benchmark i

MT NewswiresMay 18, 2023 17:42

Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore

Hyphens Pharma International (SGX:1J5) unit, Hyphens Pharma, signed an agreement with South Korean pharmaceutical company Hana Pharm (KRX:293480) to develop and commercialize Byfavo in Singapore. Byfa

MT NewswiresMay 18, 2023 14:03